Health Economics and Market Access (HEMA) at Yes2Treatment supports medical devices and pharmaceutical companies in launching new devices and treatments. We analyze the clinical evidence, determine the health economic advantages, identify pricing considerations to support the new devices / treatments introduction in the country and also support in creation of communications for early reimbursement under insurance.

This vertical not only supports the medical devices and pharmaceutical companies launch new devices and treatments but also supports a larger population to faster access these new devices / procedures for better treatment.

Kindly send us your details we will set up a time to understand your requirements.